HOME › DRUGS › HYALURONIDASE
ACTIVE SUBSTANCE / INN

HYALURONIDASE

Brand name(s): HYDASE, AMPHADASE, VITRASE, Vitragan
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
DISCONTINUED
BLA021665
Vitreous Hemorrhage
ACTIVE SUBSTANCE
Hyaluronidase
REGULATORS
FDA · EMA
SPONSORS / MAH
ISTA Pharma Limited, BAUSCH AND LOMB, AMPHASTAR PHARM
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
VITRASEBLA021640BAUSCH AND LOMBDiscontinued
VITRASEBLA021640BAUSCH AND LOMBPrescription
AMPHADASEBLA021665AMPHASTAR PHARMPrescription
HYDASEBLA021716AKORN INCDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VitraganISTA Pharma LimitedApplication withdrawnVitreous Hemorrhage

FULL INTELLIGENCE ON HYALURONIDASE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →